02:36 PM EDT, 10/02/2024 (MT Newswires) -- Establishment Labs Holdings ( ESTA ) said Wednesday that the first patients in the US received successful breast augmentations with Motiva implants.

The US Food and Drug Administration approved the implants likes week.

Two procedures were completed using Motiva SmoothSilk Ergonomix and SmoothSilk Round implants, which are designed to improve aesthetic results and reduce complications, Establishment Labs ( ESTA ) said.

Establishment Labs ( ESTA ) shares were up 14% in recent trading.

Price: 46.31, Change: +5.75, Percent Change: +14.16